⌘K

Home/Filings/4/0001213900-24-060500

4//SEC Filing

Field Katharyn 4

Accession 0001213900-24-060500

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Jul 9, 8:00 PM ET

Accepted

Jul 10, 4:10 PM ET

Size

5.4 KB

Accession

0001213900-24-060500

Insider Transaction Report

Form 4

Period: 2024-07-05

Virpax Pharmaceuticals, Inc.VRPX

Director

Transactions

Award
Stock Option (right to buy)
2024-07-05+2,500→ 2,500 total
Exercise: $0.58Exp: 2034-07-04→ Common Stock (2,500 underlying)

Footnotes (1)

[F1]The option vests in full on the twelve-month anniversary of the grant date.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0002029888

Filing Metadata

Form type: 4
Filed: Jul 9, 8:00 PM ET
Accepted: Jul 10, 4:10 PM ET
Size: 5.4 KB

View on SEC.gov